References
- Personal communication. McNeil Consumer Products Company, Fort Washington, PA
- Coles L S, Fries J F, Kraines R G, Roth S H. From experiment to experience: side effects of nonsteroidal anti-inflammatory drugs. Am J Med 1983; 74: 820–828
- Bennett W M, Henrich W L, Stoff J S. The renal effects of nonsteroidal anti-inflammatory drugs: Summary and recommendations. Am J Kid Dis 1996; 28(suppl)S56–S62
- McGiff J C, Crowshaw K, Terragno N A, Lonigro A J. Renal prostaglandins: Possible regulators of the renal actions of pressor hormones. Nature 1970; 227: 1255–1257
- Zusman R M, Keiser H R. Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture; simulation by angiotensin II bradykinin, and vasopressin. J Clin Invest 1970; 60: 215–223
- Vane J. Towards a better aspirin. Nature 1994; 367: 215–216
- Dunn M J, Hood V L. Prostaglandins and the kidney. Am J Physiol 1977; 233: F169–F187
- Wheiton A, Hamilton C W. Nonsteroidal anti-inflammatory drugs: Effects on kidney function. J Clin Pharmacol 1991; 31: 435–465
- Gutthann S P, Garcia Rodriquez L A, Raiford D S, Oliart A D, Romeu J R. Nonsteroidal anti-inflammatory drugs and the risk of hosphalization for acute renal failure. Arch Intern Med 1996; 156: 2433–2439
- Radford M G, Jr, Holley K E, Grande J P, Larson T S, Wagoner R D, Donadio J V, McCarthy J T. Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. JAMA 1996; 276: 466–469
- Kleinknecht D. Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs. Sem Nephrol 1995; 15: 228–235
- Shibasaki T, Ishimoto F, Sakai O, Joh K, Aizawa S. Clinical characterization of drug-induced allergic nephritis. Am J Nephrol 1991; 11: 174–180
- Furst D E. Clinically important interactions of nonsteroidal anti-inflammatory drugs with other medications. J Rheumatol 1988; 17(supp): 58–62
- Jung K, Scholz D. An optimized assay of alanine aminopeptidase activity in the urine. Clin Chem 1980; 26: 1251–1254
- Lockwood T D, Bosmann H B. The use of urinary N-acetyl-Beta-D-glucosaminidase in human renal toxicology 1. Partial biochemical characterization and excretion in humans and release from the isolated perfused rat kidney. Toxicol Appl Pharmacol 1979; 49: 323–336
- Ginsberg J M, Chang B S, Matarese R A, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Eng J Med 1983; 309: 1543–1546
- Bennett W M, Porter G A. Endogenous creatinine clearance as a clinical measure of glomerular filtration rate. Br Med J 1971; 4: 84–85
- Frolich J C. A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol Sci 1997; 18: 30–34
- Venturini C M, Idakson P, Needlemen P. Non-steroidal anti-inflammatory drug-induced renal failure: a brief review of the role of cyclo-oxygenase isoforms. Curr Opin Nephrol Hyperten 1998; 7: 79–82
- Ganley C J, Paget S A, Reidenberg M M. Increased renal tubular cell excretion by patients receiving chronic therapy with gold and with nonsteroidal anti-inflammatory drugs. Clin Pharmacol Therap 1989; 46: 51–55
- Ishioka T. Is tiaprofenic acid different from other NSAID's with regard to effects on renal function in the elderly?. Drugs 1988; 35(Supp 1: 95–100
- Zafirovska K G, Bogdanovska S V, Marina N, Gruev T, Lozance L. Urinary excretion of three specific renal tubular enzymes in patients treated with nonsteroidal anti-inflammatory drugs (NSAID). Renal Failure 1993; 15: 51–54